Immune clues may predict surgery risks for pancreatic cancer patients
NCT ID NCT04774198
First seen Jun 15, 2026 · Last updated Jun 17, 2026 · Updated 1 time
Summary
This study looked at 58 people scheduled for pancreatic cancer surgery to see if immune system markers could predict complications like low blood pressure or infections. Researchers collected blood samples before and after surgery to find patterns linked to poor outcomes. The goal is to better understand risks and improve recovery for future patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rigshospitalet
Copenhagen, 2100, Denmark
Conditions
Explore the condition pages connected to this study.